Use of Hepatitis B Virus DNA Quantitation To Predict Hepatitis B e Antigen Reversion in Cases of Chronic Hepatitis B
Open Access
- 1 October 2003
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 41 (10) , 4793-4795
- https://doi.org/10.1128/jcm.41.10.4793-4795.2003
Abstract
Seventy-three chronic hepatitis B patients who had either hepatitis B e antigen (HBeAg) seroconversion (group I) or HBeAg-negative disease (group II) were studied. HBV DNA levels at HBeAg seroconversion (group I) and at initial visits (group II) were significantly lower among patients who were persistently negative for HBeAg than among those who underwent HBeAg reversion.Keywords
This publication has 20 references indexed in Scilit:
- Hepatitis B Virus Genotype C Takes a More Aggressive Disease Course Than Hepatitis B Virus Genotype B in Hepatitis B e Antigen-Positive PatientsJournal of Clinical Microbiology, 2003
- Quantitative serum HBV DNA levels during different stages of chronic hepatitis B infectionHepatology, 2002
- Quantitative serum HBV DNA levels during different stages of chronic hepatitis B infectionHepatology, 2002
- Factors associated with viral breakthrough in lamivudine monoprophylaxis of hepatitis B virus recurrence after liver transplantationJournal of Medical Virology, 2002
- Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis BHepatology, 2002
- Management of hepatitis B: 2000—Summary of a workshopGastroenterology, 2001
- High-Throughput Quantitative Analysis of Hepatitis B Virus DNA in Serum Using the TaqMan Fluorogenic Detection SystemHepatology, 2000
- Hepatitis B e antigen-negative chronic hepatitis b in Hong KongHepatology, 2000
- The long-term course of chronic hepatitis BHepatology, 1999
- Genotypes, nt 1858 Variants, and Geographic Origin of Hepatitis B Virus—Large‐Scale Analysis Using a New Genotyping MethodThe Journal of Infectious Diseases, 1997